Chen Chien Pong
Department of Radiation Oncology, Scripps MD Anderson Cancer Center, San Diego, CA, USA.
J Clin Transl Hepatol. 2019 Jun 28;7(2):183-190. doi: 10.14218/JCTH.2018.00060. Epub 2019 May 27.
The role of radiotherapy in the treatment of hepatocellular carcinoma (HCC) has evolved over the past few decades with the advancement of technology and improved imaging. Radiotherapy can offer high local control rates in unresectable HCC, including cases with major vascular involvement, and can provide a modality to help bridge patients to potentially curative resection or transplantation. In metastatic cases, radiotherapy can provide good palliation. This review focuses on the common radiotherapy treatment modalities used for HCC, provides outcome comparisons of these radiotherapy techniques to outcomes with other treatment modalities for HCC, and highlights the discrepancy of the role of radiotherapy in HCC amongst the current available treatment guidelines.
在过去几十年中,随着技术的进步和成像技术的改进,放射治疗在肝细胞癌(HCC)治疗中的作用不断演变。放射治疗可在不可切除的HCC中实现较高的局部控制率,包括伴有主要血管受累的病例,并可为帮助患者过渡到可能的根治性切除或移植提供一种方式。在转移性病例中,放射治疗可提供良好的姑息治疗。本综述重点关注用于HCC的常见放射治疗方式,将这些放射治疗技术的结果与HCC其他治疗方式的结果进行比较,并突出当前可用治疗指南中放射治疗在HCC中的作用差异。